Video. It is an illness that affects around 100,000 people in the UK but there is still no known cure for those who suffer day in, day out. Now a study has shown that people living with Multiple Sclerosis in the south could benefit from a unique combination of therapies.
The MS Society has given £40,000 to help fund the research, and volunteers have reported marked improvement in their mobility. Sally Simmonds explains.
A new drug has been approved by the European Medicines Agency which could offer better treatment to patients with multiple sclerosis. Alemtuzumab will give people who have the disease the chance to live without the side effects for much longer.
Symptoms of the disease can include loss of physical skills, sensation, vision and bladder control.
Professor Herman Waldmann was involved in the early discovery work of the antibody drug called Campath-1H at Cambridge University. It was originally used to treat leukaemia. He continued to study the drug for two decades while at Oxford University.
A man from Kent will travel almost 3,000 miles on hismotorbike in support of his wife who suffers from multiple sclerosis.
Paul Thomas will start his 7 day journey on June 1 at Folkestone harbour to raise money for the MS Society.
He will travel around the coast of Britain without using motorways.
Paul's wife Shelly was diagnosed with MS in 2001 and her symptoms include spasms, losing the use of legs and temporary blindness.
Shelly says she’s incredibly proud of her husband: “He has such a big heart and doing this challenge to raise money and awareness and show support for me and others with this condition is beyond words."